European Union: Intellectual Property & Life Sciences 2013: Legal Developments You Need To Know About

Last Updated: 25 January 2013
Article by Mark A. Prinsley, Sarah Byrt, Jonathan Radcliffe and Sangeeta Puran

Keywords: EU clinical trials regulation, EU patent package, patent box, R&D tax credit


This is a short guide to some of the key legal developments for intellectual property in the life sciences sector in 2013.

The developments include a proposed new EU Clinical Trials Regulation, progress of the EU unitary patent package, the UK Patent Box and R&D tax credit coming into effect, reform of the research and Bolar exceptions and a proposed new EU legislative framework for medical devices. They also include developments relating to database rights, exceptions to copyright law, changes to UK design law and a new EU Regulation on data protection.

For further information or advice, please contact your usual contact at Mayer Brown or any of the Intellectual Property Partners in our London Office whose details can be found at the end of this guide.

1 January 2013

Binding Corporate Rules (BCRs) for data processors

Since 1 January 2013 data processors have been able to implement BCRs to facilitate the movement of personal data outside the EU. The Article 29 Working Party (the influential data protection advisory group set up by the EU) has launched this non-obligatory option so that processors of personal data (e.g. technology outsourcing providers), acting on behalf of data controller clients, can transfer personal data in accordance with EU rules on data protection. This will be welcome news to data processors and data controllers, particularly those that undertake large-scale international data transfers. Data controllers and processors can now use approved BCRs for a processor to ensure that transfers of data outside the EU comply with EU data protection law, thereby avoiding the need to negotiate complicated data protection safeguards for each contract.


New Clinical Trials Regulation and repeal of the Clinical Trials Directive

In July 2012, following a period of public consultation, the European Commission adopted a proposal for a Regulation on clinical trials on medicinal products for human use, repealing the current Clinical Trials Directive. According to the Commission, the Clinical Trials Directive has been heavily criticised by all stakeholders and the number of clinical trials has fallen by 25 per cent in recent years. The proposal aims to harmonise and streamline clinical trials legislation across the EU. It is expected that the proposed Regulation will have its first reading before the European Parliament in the first half of 2013.

January/February 2013

EU data protection law reforms

A draft report by the EU Committee on Civil Liberties, Justice and Home Affairs (LIBE) on the amendments to the proposed Data Protection Regulation is expected early in 2013. The Regulation would harmonise data protection rules across EU member states. The proposed changes include the mandatory appointment of a data protection officer for certain organisations; mandatory notification of all data breaches to a regulator within 24 hours; direct liability for data processors in some areas of compliance; and fines of up to 2 per cent of annual worldwide turnover for serious compliance failures. Proposals to replace the current Data Protection Directive with a new legislative framework, including a new Regulation, were published by the European Commission in January 2012.

January - March 2013

Confidentiality and passing off

In January 2012, the European Commission published its first study on the protection in EU member states for trade secrets and against parasitic copying (e.g. copycat or lookalike copying). This concluded that the scope and effectiveness of protection varied between member states. The results of a second study on the benefits and negative effects of protecting trade secrets are due in the first quarter of 2013. A subsequent public consultation on the protection of business know-how opened in December 2012 and is due to close in March 2013.

February 2013

EU unitary patent package

On 11 December 2012, the European Parliament voted in favour of the new EU unitary patent package, which will allow inventors to apply for a unitary patent covering all the EU member states, something that proponents of the package believe will result in a more cost effective and consistent European patent regime. The new framework will come into effect on 1 January 2014 or earlier, if 13 states have signed up to the international agreement on the Unified Patent Court (and provided the UK, France and Germany are among them). The international agreement on the Unified Patent Court will be open for signature in February 2013. The precise arrangements for a European patent court are still unclear, with the European Parliament agreeing a set of principles only. The draft Rules of Procedure are to be formally published for consultation when all member states approve the agreement in principle.

February 2013

Unjustified threats of infringement (designs, patents and trade marks)

The UK Law Commission expects to open a three-month consultation in February 2013 on whether to repeal, reform or extend legislation relating to unjustified threats of action for infringement of designs, patents and trade marks. Currently in the UK, there are legal risks for those who send letters before action (cease and desist letters) in some IP cases. Where it is found there is no basis to an allegation of infringement, or no genuine intention to litigate, the threat may be deemed unjustified. In these instances, the recipient of a threat of action has a statutory right to claim damages. The Law Commission thinks that the current legal framework is inconsistent and complex.

1 April 2013

UK Patent Box and R&D tax credit

The UK's Patent Box regime, which allows a lower rate of UK corporation tax to be applied to worldwide profits from the exploitation of qualifying patents, comes into effect on 1 April 2013. The full tax benefits will be phased in over a five-year period. The Government will also introduce an 'above the line' R&D tax credit (i.e. a credit against corporation tax) in 2013.

Spring 2013

Online personalised pricing practices

The UK Office of Fair Trading (OFT) launched a call for information in November 2012 with respect to how the use of data about consumers affects online markets. The OFT is considering whether online retailers use data about users to modify prices offered to them on websites; if this is harmful, what is acceptable conduct; and whether any consumer protection laws are being breached. The OFT expects to publish its findings in Spring 2013.


Patent cases before the UK Supreme Court

Cases before the Supreme Court in 2013 include three appeals on issues of patent law. The first two appeals concern the same patent for a bulk container used for transporting liquids, consisting of an outer cage into which a plastic container is fitted. The issues to be considered by the Supreme Court are (i) when the replacement of part of a patented product amounts to 'making' that product, which thereby infringes the patent; and (ii) when can the court award costs to an exclusive licensee of the infringed patent, if the licensee did not register its licence with the Patent Office within six months of becoming exclusive licensee, as required to do so by the Patents Act. The third appeal concerns a patent for a medicine to inhibit hypertension and cardiac insufficiency. The issue before the court concerns the availability of a remedy where an injunction is discharged because a UK patent is subsequently invalidated but manufacture of the product would have infringed a valid patent in a different jurisdiction. We will provide further updates over the course of the year.


Technology transfer block exemption

The Technology Transfer Block Exemption Regulation (TTBER) creates a safe harbour for technology transfer agreements (particularly patent and know-how licences) under EU competition law. The existing framework is due to expire at the end of April 2014. The Commission will review the TTBER and associated guidelines in 2013. Its consultation on how the existing TTBER and guidelines have worked in practice, and what improvements are possible, closed in February 2012.


Database rights: More decisions due in Football Dataco Ltd v Sportradar GmbH

In October 2012, the Court of Justice of the European Union (CJEU) ruled that, where a website operator targets and then provides material which infringes database rights to recipients based in an EU member state over the internet, the act of infringement occurs at least in the EU member state where those recipients are located. This makes it easier for rights-owners to sue in their chosen territory. The decision was a blow to Sportsradar, which had hoped that the CJEU would rule that the case should only be heard in Germany, where Sportsradar's server is based. A trial on the primary liability of the defendants will take place in 2013. In addition, the Court of Appeal is due to hand down a decision in early 2013 following the High Court's ruling in May 2012 on the aspects of the case that were unaffected by the referral to the CJEU (one of the defendants – not Sportsradar – was found jointly liable for users' infringements of Dataco's database rights).


Innocent infringement of registered design rights

Following a UK Intellectual Property Office (IPO) consultation in 2010, the IPO announced in August 2012 that it will introduce rules that remove the limitation on liability of innocent infringers of UK-registered designs and allow the owner of a UK-registered design to seek an account of profits – but not damages – from an innocent infringer of the design as soon as possible. There is currently an anomaly between the financial remedies for an innocent infringement of UK registered and Community registered designs. Whereas an innocent infringer of a UK-registered design is exempt from an account of profits and damages, an innocent infringer of a Community design may be liable for an account of profits or damages. The existing provisions for unintentional infringement of Community designs will be amended to mirror the change (so that an account of profits only will be available).


Consultation on changes to UK design law

Following the Government's 2012 consultation on its proposals for improving the UK designs legal framework (which closed in October last year), it has stated that further consultation in 2013 should focus on improving the way in which existing design rights work rather than completely restructuring UK design law.


Reform of the Misleading and Comparative Advertising Directive

Following its consultation in 2011, the European Commission intends to introduce proposals to amend the Misleading and Comparative Advertising Directive in 2013. The Directive protects traders and consumers against misleading advertising. The proposed changes are likely to include a list of misleading marketing practices that are banned and rules for effective penalties.

1 October 2013

Reform of the research and Bolar exceptions

In October 2012, the IPO launched a consultation on proposals to amend the Patents Act so that it provides a broader exception to patent infringement for activities involved in preparing or running clinical or field trials which use innovative drugs. This closed in December 2012. Subject to the outcome of the consultation, the IPO intends the proposed legislative changes are implemented by 1 October 2013.

October 2013

Copyright exceptions

On 20 December 2012, the Government published a report setting out its proposed changes to the framework of copyright 'exceptions'. The changes would allow third parties to use copyright works for economically and/or socially useful purposes without needing to obtain permission from copyright owners. The proposals include introducing a private copying exception allowing copying from one device to another for personal use; a fair dealing exception for educational purposes; a fair dealing exception to allow copying for parody; allowing copying for non-commercial research and private study; and allowing libraries (and similar organisations) to make preservation copies. The Government intends to make the draft regulations available for technical comments and wants all of the proposals to take effect in October 2013.


Supplementary Protection Certificates (SPCs): more questions referred to the CJEU

In October 2012, the UK High Court referred yet more questions on the interpretation of the SPC Regulation to the CJEU. These relate to whether a marketing authority that is not granted pursuant to the procedure laid down in Directive 2001/83/EC constitutes the "first authorisation to place the product on the market" for the purposes of Article 13(1) (which sets out how to calculate the duration of an SPC) and whether a product that is subject to such a marketing authority qualifies for the grant of an SPC under Article 2 (which defines the scope of the SPC Regulation).

Late 2013

Reform of EU medical device legislation

In September 2012, the European Commission proposed a new legislative framework for medical devices. Proposed changes include extending the scope of the legislation; placing clearer responsibilities on manufacturers, importers and distributors; strengthening the rules for clinical investigation of devices; and improving traceability and monitoring of products on the EU market. The proposed Regulations are due for their first hearing before the European Parliament late in 2013.


IP rulings from the CJEU

A number of cases progressing through the CJEU will have implications for various points of intellectual property law, including: the use of devices specifically designed to circumvent protection measures on video games; the liability of service providers who give access to protected films via the internet; interpretation of the EU Database Directive (including whether the cumulative effect of repeated re-utilisation of 'insubstantial' parts of a database amounts to re-utilisation of a 'substantial' part); and jurisdictional issues relating to trade mark infringement and cross-border copyright infringement. We will provide further updates over the course of the year.

Originally published on 21 January 2013.

Visit us at

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2013. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions